These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 26184304)

  • 21. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease.
    Ono K; Hamaguchi T; Naiki H; Yamada M
    Biochim Biophys Acta; 2006 Jun; 1762(6):575-86. PubMed ID: 16644188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
    Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferulic Acid in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies.
    Wang EJ; Wu MY; Lu JH
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid.
    Yan JJ; Cho JY; Kim HS; Kim KL; Jung JS; Huh SO; Suh HW; Kim YH; Song DK
    Br J Pharmacol; 2001 May; 133(1):89-96. PubMed ID: 11325798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferulic acid: a natural antioxidant against oxidative stress induced by oligomeric A-beta on sea urchin embryo.
    Picone P; Nuzzo D; Di Carlo M
    Biol Bull; 2013 Feb; 224(1):18-28. PubMed ID: 23493505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
    Chen Z; Digiacomo M; Tu Y; Gu Q; Wang S; Yang X; Chu J; Chen Q; Han Y; Chen J; Nesi G; Sestito S; Macchia M; Rapposelli S; Pi R
    Eur J Med Chem; 2017 Jan; 125():784-792. PubMed ID: 27736684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-Amyloid amorphous aggregates induced by the small natural molecule ferulic acid.
    Bramanti E; Fulgentini L; Bizzarri R; Lenci F; Sgarbossa A
    J Phys Chem B; 2013 Nov; 117(44):13816-21. PubMed ID: 24168390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oxidative stress and Alzheimer's disease].
    Liu XJ; Yang W; Qi JS
    Sheng Li Xue Bao; 2012 Feb; 64(1):87-95. PubMed ID: 22348966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Pan W; Hu K; Bai P; Yu L; Ma Q; Li T; Zhang X; Chen C; Peng K; Liu W; Sang Z
    Bioorg Med Chem Lett; 2016 May; 26(10):2539-2543. PubMed ID: 27072909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid Beta toxicity and Alzheimer's disease.
    Hajieva P; Behl C
    Curr Pharm Des; 2006; 12(6):699-704. PubMed ID: 16472160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease.
    Mohmmad Abdul H; Butterfield DA
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):140-8. PubMed ID: 15955457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
    Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
    J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis.
    Kawada H; Blessing K; Kiyota T; Woolman T; Winchester L; Kador PF
    J Alzheimers Dis; 2015; 44(1):297-307. PubMed ID: 25227315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.